CVS, Sharecare launch digital pharmacy savings card; Eli Lilly, Evidation expand data platform partnership; and more digital health deals

Also: Case Western Reserve University's rowing team will now wear VivaLNK's wearable patches and Memorial Sloan Kettering Cancer Center inks a deal with MyHealthDirect.
By Dave Muoio
03:35 pm
Share

CVS Caremark and health data management company Sharecare last week announced the launch of a digital pharmacy savings card for under-covered individuals. Accessed through an app, the Sharecare Rx program will provide discounts on CVS Caremark network drugs as well as search for lower drug prices. The digital card will be accepted at more than 68,000 in-network pharmacies.

“Whether treating strep throat or managing a chronic condition, the modern healthcare experience cannot be comprehensive without medications, yet the burdens of choice and cost placed on people can be overwhelming,” Jeff Arnold, cofounder, chairman and CEO of Sharecare, said in a statement. “By partnering with CVS Caremark to build Sharecare Rx into our platform, we are removing barriers to empower consumers to truly manage all their health in one place. We are also actively working with our health plan and employer partners to integrate their formulary coverage and pricing into Sharecare so their members can seamlessly access their prescription benefits, as well as information and tools to help them adhere to a healthier regimen.”

...

Eli Lilly and Company and Evidation Health have broadened the scope of their partnership, which will now include a multi-year agreement giving Lilly access to Evidation’s Andromeda data platform. As a result, Lilly researchers coming from various portfolio will be able to use the network’s device-collected patient data and insight-generating models to, for instance, better support the construction of a more effective connected diabetes management ecosystem.

"Digital health advancements, including mobile devices and wearables, have the potential to improve and personalize health outcomes," Divakar Ramakrishnan, Lilly's chief digital officer, said in a statement. "By leveraging Evidation's Andromeda platform, Lilly's scientists are gaining a deeper understanding of the physiological, environmental, and contextual indicators that can help shape future advancements in medicine and medicine delivery.”

Case Western Reserve University crew team will be outfitted with VivaLNK’s Vital Scout wearable patches for an upcoming study of stress and physical exertion thanks to an agreement between the two entities. The ECG sensor-equipped patches will not only be used to measure heart rate, respiration rate, sweat rate, individual stress and the impact of acute-to-chronic workloads on each of these.

“Whether treating strep throat or managing a chronic condition, the modern healthcare experience cannot be comprehensive without medications, yet the burdens of choice and cost placed on people can be overwhelming,” Jeff Arnold, co-founder, chairman and CEO of Sharecare, said in a statement. “By partnering with CVS Caremark to build Sharecare Rx into our platform, we are removing barriers to empower consumers to truly manage all their health in one place. We are also actively working with our health plan and employer partners to integrate their formulary coverage and pricing into Sharecare so their members can seamlessly access their prescription benefits, as well as information and tools to help them adhere to a healthier regimen.”

Memorial Sloan Kettering Cancer Center has launched new online patient self-scheduling system built on MyHealthDirect’s digital care coordination technology. The system integrates directly with Epic EMR, allowing patients to schedule appointments for lymphoma, myeloma, breast surgery and other conditions in real time.

"It is our honor to offer a scheduling experience that aligns with Memorial Sloan Kettering's mission to provide highly individualized, exceptional care to each patient," Jason Kressel, COO at MyHealthDirect, said in a statement.

Onduo, a Verily-Sanofi joint venture focused on digitally-driven diabetes management, will make Orpyx Medical Technologies’ FDA-cleared SurroSense Rx system available to its members. The system consists of a thin sensor that is placed in a patient’s shoes and a wirelessly connected smartwatch, which displays readings and alerts to the user when dangerous pressure levels are detected, potentially protecting patients from diabetic foot ulcers and resulting limb loss.

"Managing diabetes is a 24-7 job and we want to make access to care and monitoring easier for members," Dr. Josh Riff, CEO of Onduo, said in a statement. "We are thrilled to partner with Orpyx to help keep members walking and living actively in our community.”

Garmin and medical-grade monitor maker ActiGraph recently announced a new partnership to begin applying the former’s devices into more medical research and patient care. Thanks to the new partnership, the pair will be applying ActiGraph’s CentrePoint data analytics platform to Garmin’s consumer-grade wearables.

“Combining the sensor data from Garmin wearables with the data capture and analytical expertise of the ActiGraph platform creates a powerful solution for many different patient monitoring applications,” Travis Johnson, global product lead at Garmin Health, said in a statement.

Share